$3.22
-0.15 (-4.45%)
USD · as of 2026-08-18 · marketstack
Clinical trials
catalyst calendar across sponsors →Studies where INBS is the lead sponsor, as filed with ClinicalTrials.gov. Completion dates are the sponsor's own projected windows and are revised as a study runs. Active studies first, then completed and stopped — newest readout first within each.
2 interventional · 4 observational
Held by 0 tracked-famous managers · FINRA short interest 1.0 days to cover (settled 2026-07-31) · government filings 180d: none disclosed
| Study | Phase | Status | Interventions | Conditions | Enrollment | Primary completion | Readout in | Updated |
|---|---|---|---|---|---|---|---|---|
| Interference and Stability Evaluation of the Intelligent Fingerprinting Drug Screening SystemNCT07758907Effect of Potential InterferentsNon-randomized · Open-label · Other | Not applicable | Enrolling by invitation | Device: Device storage condition, Interferent application | Interference With Routine Analytical Tests, Stability of in Vitro Diagnostic Reagents, Illicit Drug Use | 95 | Aug 2026 | ≤ 12 d | 2026-08-11 |
| Method Comparison of Intelligent Fingerprinting Drug Screening SystemNCT07650136observationalSensitivity | — | Recruiting | — | Drug Abuse Illicit | 144 | 2026-07-31 | — | 2026-08-03 |
| Drug Screening System Method ComparisonNCT06618183observationalMethod Comparison | — | Recruiting | Diagnostic test: Fingerprint sweat drug screen, Fingerprint sweat laboratory analysis | Reagent Kits, Diagnostic | 135 | 2024-11-30 | — | 2024-10-01 |
| Usability Evaluation of the Intelligent Fingerprinting Drug Screening SystemNCT07758777Operator TestingNon-randomized · Single-masked · Other | Not applicable | Completed | Diagnostic test: Diagnostic procedures · Device: Drug Screening | Healthy Adult Participants | 45 | 2026-07-24actual | — | 2026-08-11 |
| Cutoff Assessment for Codeine in Fingerprint Sweat Relative to Oral Fluid, Following Controlled, Oral Administration of Codeine Phosphate Tablets to 40 Healthy AdultsNCT07755267observationalFingerprint sweat codeine cutoff | — | Completed | Device: Determination of codeine phosphate | Healthy Adult | 43 | 2026-02-06actual | — | 2026-08-10 |
| PK of Codeine and Metabolites in Human Fingerprint Sweat, Oral Fluid, Blood and UrineNCT06519045observationalMaximum concentration (Cmax) of codeine and codeine-6-glucuronide in fingerprint sweat, oral fluid, plasma, and urine | — | Unknown status | Device: Intelligent Fingerprinting Drug Screening System | Pharmacokinetics | 40 | 2024-08-31 | — | 2024-07-25 |
Primary completion is the date the sponsor filed with the registry — their own projection, revised whenever they revise it, unless the row is marked actual.
Source: ClinicalTrials.gov, retrieved 2026-08-19